<DOC>
	<DOCNO>NCT01524094</DOCNO>
	<brief_summary>The purpose study see difference survival two different treatment strategy colorectal peritoneal surface disease . The control arm administer currently consider standard treatment palliative systemic chemotherapy . The experimental arm receive combination treatment cytoreductive surgery intraperitoneal chemotherapy . The investigator hypothesis combination treatment improve overall survival .</brief_summary>
	<brief_title>Cytoreduction Intraperitoneal Chemotherapy Versus Systemic Chemotherapy Colorectal Peritoneal Carcinomatosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>Metastatic disease peritoneum colon rectum ( least two isolated site disease ) verify primary tumor adenocarcinoma colon rectum Potential resectability judge treat surgeon Patient available followup accord study protocol Signed informed consent Extraabdominal metastases liver metastasis Paraaortic inoperable lymph node metastasis Clear indication surgery ( obstruction , bleed peritonitis ) Prior treatment either arm study Clinical histopathological diagnosis Peritoneal Pseudomyxoma Age &gt; 80 Contraindications chemotherapy Pregnancy breastfeed Ongoing infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>cytoreductive surgery</keyword>
	<keyword>intraperitoneal chemotherapy</keyword>
	<keyword>systemic chemotherapy</keyword>
	<keyword>Peritoneal Metastatic Disease From Colon Rectum</keyword>
</DOC>